Literature DB >> 692605

Possible interaction of sulfinpyrazone with coumarins.

J W Davis, L E Johns.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 692605     DOI: 10.1056/NEJM197810262991715

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  9 in total

1.  Hazards of sulphinpyrazone.

Authors:  D Mattingly; M Bradley; P J Selley
Journal:  Br Med J       Date:  1978 Dec 23-30

Review 2.  Importance of drug enantiomers in clinical pharmacology.

Authors:  K Williams; E Lee
Journal:  Drugs       Date:  1985-10       Impact factor: 9.546

3.  Biphasic sulphinpyrazone-warfarin interaction.

Authors:  G G Nenci; G Agnelli; M Berrettini
Journal:  Br Med J (Clin Res Ed)       Date:  1981-04-25

Review 4.  Clinical pharmacokinetics and potentially important drug interactions of sulphinpyrazone.

Authors:  A K Pedersen; P Jakobsen; J P Kampmann; J M Hansen
Journal:  Clin Pharmacokinet       Date:  1982 Jan-Feb       Impact factor: 6.447

5.  The effect of sulphinpyrazone on oxidative drug metabolism in man: inhibition of tolbutamide elimination.

Authors:  J O Miners; T Foenander; S Wanwimolruk; A S Gallus; D J Birkett
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

6.  Enhanced drug metabolism after sulfinpyrazone treatment in patients aged 50 to 60 years.

Authors:  E Walter; C Staiger; J de Vries; E Weber; W Bitzer; M Degott; K Jüngling
Journal:  Klin Wochenschr       Date:  1982-11-15

Review 7.  Sulfinpyrazone: a review of its pharmacological properties and therapeutic use.

Authors:  E H Margulies; A M White; S Sherry
Journal:  Drugs       Date:  1980-09       Impact factor: 9.546

8.  Interaction of sulphinpyrazone with warfarin.

Authors:  J O Miners; T Foenander; S Wanwimolruk; A S Gallus; D J Birkett
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

Review 9.  Antiplatelet drugs: clinical pharmacology and therapeutic use.

Authors:  A S Gallus
Journal:  Drugs       Date:  1979-12       Impact factor: 9.546

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.